Reiner Ziegler

Title: Reiner Ziegler: Innovator in Lipid Metabolism Treatment

Introduction

Reiner Ziegler is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of lipid metabolism through his innovative research and patenting efforts. His work has implications for the treatment and prophylaxis of lipid disorders, showcasing the importance of scientific advancements in healthcare.

Latest Patents

Ziegler holds a patent for the "Combination of cerivastatin and fibrates." This invention relates to the combination of the 3-hydroxy-3-methylglutaryl-coenzyme A inhibitor (HMG-CoA inhibitor) cerivastatin with fibrates. It is aimed at improving the prophylaxis and treatment of disorders of lipid metabolism. He has 1 patent to his name, reflecting his focused contributions to this area of research.

Career Highlights

Reiner Ziegler is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His role at Bayer has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in lipid metabolism.

Collaborations

Ziegler has worked alongside notable colleagues such as Fritz Schückler and Ulrike Schopen. These collaborations have enhanced the research environment and fostered innovation in the development of new treatments.

Conclusion

Reiner Ziegler's work in the combination of cerivastatin and fibrates represents a significant advancement in the treatment of lipid metabolism disorders. His contributions to Bayer Aktiengesellschaft and collaborations with esteemed colleagues highlight the importance of teamwork in scientific innovation.